Cost-effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors for Patients With Heart Failure and Preserved Ejection Fraction-Living on the Edge
- PMID: 36870043
- PMCID: PMC10175229
- DOI: 10.1001/jamacardio.2023.0087
Cost-effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors for Patients With Heart Failure and Preserved Ejection Fraction-Living on the Edge
Comment on
-
Cost-effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors for the Treatment of Heart Failure With Preserved Ejection Fraction.JAMA Cardiol. 2023 May 1;8(5):419-428. doi: 10.1001/jamacardio.2023.0077. JAMA Cardiol. 2023. PMID: 36870047 Free PMC article.
References
-
- Cohen Laura, et al. Cost-effectiveness of SGLT2 Inhibitors for the Treatment of Heart Failure with Preserved EjectionFraction.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical